The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of liposomal irinotecan combined with cadonilimab as second-line treatment for extensive-stage small cell lung cancer (ES-SCLC): A prospective, single arm phase II clinical study.
 
Xuquan Jing
No Relationships to Disclose
 
Yaru Tian
No Relationships to Disclose
 
Zhe Wang
No Relationships to Disclose
 
Ning Tang
No Relationships to Disclose
 
Guangjian Yang
No Relationships to Disclose
 
Xiaomeng Liu
No Relationships to Disclose
 
Haiyong Wang
No Relationships to Disclose
 
Hui Zhu
No Relationships to Disclose